Cargando…
国产甲磺酸伊马替尼治疗慢性髓性白血病慢性期早期疗效和安全性的前瞻性、多中心临床研究
OBJECTIVE: To evaluate the early hematologic, cytogenetic and molecular responses in newly diagnosed patients with chronic myelogenous leukemia in chronic phase (CML-CP) and initially treated with a generic imatinib (Xinwei), manufactured by Jiansu Hansoh Pharmaceutical Group Co., Ltd. METHODS: 107...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348277/ https://www.ncbi.nlm.nih.gov/pubmed/26462633 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.08.005 |